Aerovate Therapeutics Inc Current Liabilities Ratio 2 year CAGR is 208.53% for the year ending December 31, 2023, a 442.40% change year over year. The current liabilities ratio measures the proportion of a company's current liabilities in relation to its total assets. It is calculated by dividing current liabilities by total assets. This ratio indicates the percentage of a company's total assets that are financed by current liabilities, such as accounts payable and short-term debt. It helps assess the company's short-term solvency and its ability to meet immediate obligations. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.